What is King Pharmaceuticals's income from continuing ops?

King Pharmaceuticals (KG) reported income from continuing ops of -$0.90 in Q1 2026.

How has King Pharmaceuticals's income from continuing ops changed year-over-year?

King Pharmaceuticals's income from continuing ops decreased by 542.9% year-over-year, from -$0.14 to -$0.90.

What does income from continuing ops mean?

Net income from business operations that are expected to continue, excluding gains or losses from discontinued segments. The best measure of ongoing earning power.

King Pharmaceuticals KG Income from Continuing Ops

Income from Continuing Ops at other companies

Tiptree Inc.TIPT

——

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-71.3%

Enterprise value$184.93M-52.3%

P/E1.2×—

P/S1.6×-27.7×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsPerBasicShare.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's income from continuing ops.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's income from continuing ops?: King Pharmaceuticals (KG) reported income from continuing ops of -$0.90 in Q1 2026.
How has King Pharmaceuticals's income from continuing ops changed year-over-year?: King Pharmaceuticals's income from continuing ops decreased by 542.9% year-over-year, from -$0.14 to -$0.90.
What does income from continuing ops mean?: Net income from business operations that are expected to continue, excluding gains or losses from discontinued segments. The best measure of ongoing earning power.